Skip to main content
. 2018 Nov 12;19(1):187–194. doi: 10.3892/mmr.2018.9646

Figure 2.

Figure 2.

Immunophenotypes of hBSCs. hBSCs at passage 3 were labeled with antibodies against (A) mesenchymal stem cell markers (CD13, CD29, CD73, CD90 and CD105), (B) hematopoietic stem cell markers (CD14, CD19, CD31, CD34 and CD45), (C) HLA-ABC and HLA-DR, and (D) CD44, and then analyzed by fluorescence-activated cell sorting. Representative histograms are demonstrated (purple). The respective isotype control is indicated by a green line. hBSCs, human bladder-derived mesenchymal stromal cells; CD, cluster of differentiation; HLA, human leukocyte antigen.